메뉴 건너뛰기




Volumn 66, Issue 2, 2014, Pages 251-252

Adjuvant radiation following radical prostatectomy: What are the known unknowns?

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 84904035971     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.04.023     Document Type: Editorial
Times cited : (5)

References (9)
  • 1
    • 84904035686 scopus 로고    scopus 로고
    • Adjuvant radiotherapy versus wait-and-see ffter radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial
    • T. Wiegel, D. Bartkowiak, and D. Bottke et al. Adjuvant radiotherapy versus wait-and-see ffter radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial Eur Urol 66 2014 243 250
    • (2014) Eur Urol , vol.66 , pp. 243-250
    • Wiegel, T.1    Bartkowiak, D.2    Bottke, D.3
  • 2
    • 84870485783 scopus 로고    scopus 로고
    • Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomized controlled trial (EORTC trial 22911)
    • M. Bolla, H. van Poppel, and B. Tombal et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911) Lancet 380 2012 2018 2027
    • (2012) Lancet , vol.380 , pp. 2018-2027
    • Bolla, M.1    Van Poppel, H.2    Tombal, B.3
  • 3
    • 59549095954 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial
    • I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial J Urol 181 2009 956 962
    • (2009) J Urol , vol.181 , pp. 956-962
    • Thompson, I.M.1    Tangen, C.M.2    Paradelo, J.3
  • 4
    • 84856365558 scopus 로고    scopus 로고
    • Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy
    • A.J. Stephenson, M. Bolla, and A. Briganti et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy Eur Urol 61 2012 443 451
    • (2012) Eur Urol , vol.61 , pp. 443-451
    • Stephenson, A.J.1    Bolla, M.2    Briganti, A.3
  • 5
    • 33751018522 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
    • I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
    • (2006) JAMA , vol.296 , pp. 2329-2335
    • Thompson, I.M.1    Tangen, C.M.2    Paradelo, J.3
  • 6
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Amer Stat Assoc 94 1999 496 509
    • (1999) J Amer Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.P.1    Gray, R.J.2
  • 7
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • C.R. Pound, A.W. Partin, and M.A. Eisenberg et al. Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberg, M.A.3
  • 8
    • 34447332283 scopus 로고    scopus 로고
    • Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy
    • C. Parker, M.R. Sydes, and C. Catton et al. Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy BJU Int 99 2007 1376 1379
    • (2007) BJU Int , vol.99 , pp. 1376-1379
    • Parker, C.1    Sydes, M.R.2    Catton, C.3
  • 9
    • 84904041507 scopus 로고    scopus 로고
    • A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: Background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial
    • M. Pearse, C. Fraser-Browne, and I.D. David et al. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial BJU Int 113 Suppl S2 2014 7 12
    • (2014) BJU Int , vol.113 , Issue.SUPPL. S2 , pp. 7-12
    • Pearse, M.1    Fraser-Browne, C.2    David, I.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.